Skip to content

Demonstration research on prevention and treatment of primary open angle glaucoma in hospital linkage community

Demonstration research on prevention and treatment of primary open angle glaucoma in hospital linkage community

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018658
Enrollment
Unknown
Registered
2018-10-02
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary open angle glaucoma

Interventions

TCM treatment group:TCM intervention therapy
Control group:No intervention

Sponsors

Eye Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent form; 2. Meet the diagnostic criteria for primary open angle glaucoma: (1) pathological intraocular pressure increased, 24 h intraocular pressure peak exceeded 21 mm Hg; (2) having glaucoma optic disc changes and/or retinal optic nerve fiber layer defects; (3) having glaucomatous visual field defects; (4) The anterior chamber angle is open. Among the above 4 items, 1, 2, and 3 items have two of them, and those with open anterior chamber angles can be diagnosed. 3. Aged 18 to 80 years old; 4. Intraocular pressure is controlled at the target intraocular pressure level; 5. TCM syndrome differentiation is a syndrome of qi deficiency and blood stasis or yin deficiency and blood stasis; 6. Be able to understand and be willing to receive treatment according to the research protocol, and can return to the request as required.

Exclusion criteria

Exclusion criteria: 1. Patients who do not meet the inclusion criteria; 2. Patients diagnosed with primary chronic angle-closure glaucoma; 3. The intraocular pressure is out of control; 4. Patients with severe heart, liver and kidney dysfunction, hypertension, and diabetes; 5. Women during pregnancy or lactation; 6. Participate in other clinical trials; 7. Can not cooperate with this study, or can not cooperate with follow-up.

Design outcomes

Primary

MeasureTime frame
vision;intraocular pressure;Field of vision;Ophthalmoscope (C/D);Slit-lamp (anterior segment);

Secondary

MeasureTime frame
Optical coherence tomography (OCT);Type A behavior scale;Scale of quality of life in patients with visual impairment;Visual impairment scale;TCM Syndrome Self-Assessment Scale;

Countries

China

Contacts

Public ContactZhang Lixia

Eye Hospital of China Academy of Chinese Medical Sciences

zhanglixia77@126.com+86 15601005070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026